AGILE: A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Ivosidenib in Combination with Azacitidine in Adult Patients with Previously Untreated Acute Myeloid Leukemia with an IDH1 Mutation

被引：7

作者：

Montesinos Fernandez, Pau ^{[1
]}

Recher, Christian ^{[2
,3
]}

Doronin, Vadim ^{[4
]}

Calado, Rodrigo T. ^{[5
]}

Jang, Jun Ho ^{[6
]}

Miyazaki, Yasushi ^{[7
]}

Wang, Jianxiang ^{[8
]}

Gianolio, Diego A. ^{[9
]}

Daigle, Scott R. ^{[9
]}

Winkler, Thomas ^{[9
]}

Zhang, Vickie ^{[9
]}

Paschka, Peter ^{[10
]}

机构：

[1] Hosp Univ & Politecn La Fe, Valencia, Spain

[2] CHU Toulouse, Inst Univ Canc Toulouse Oncopole, Toulouse, France

[3] Univ Toulouse III, Toulouse, France

[4] City Clin Hosp 40, St Petersburg, Russia

[5] Univ Sao Paulo, Ribeirao Preto Sch Med, Sao Paulo, Brazil

[6] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Seoul, South Korea

[7] Nagasaki Univ Hosp, Atom Bomb Dis Inst, Nagasaki, Japan

[8] Peking Union Med Coll, Inst Hematol Hosp Blood Dis, Beijing, Peoples R China

[9] Agios Pharmaceut Inc, Cambridge, MA USA

[10] Univ Ulm, Ulm, Germany

来源：

BLOOD | 2019年 / 134卷

关键词：

D O I：

10.1182/blood-2019-123045

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2593

引用

页数：4

共 50 条

[1] AGILE: A phase 3, multicenter, randomized, placebo-controlled study of ivosidenib in combination with azacitidine in adult patients with previously untreated acute myeloid leukemia with an IDH1 mutation.
Stein, Eytan
Dinardo, Courtney Denton
Jang, Jun Ho
Miyazaki, Yasushi
Martinez, Roberto Ovilla
Auer, Julia
Zhang, Vickie
Koralek, Daniel O.
Wu, Bin
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[2] AGILE: A Global, Randomized, Double-Blind, Phase 3 Study of Ivosidenib plus Azacitidine Versus Placebo plus Azacitidine in Patients with Newly Diagnosed Acute Myeloid Leukemia with an IDH1 Mutation
Montesinos, Pau
Recher, Christian
Vives, Susana
Zarzycka, Ewa
Wang, Jianxiang
Bertani, Giambattista
Heuser, Michael
Calado, Rodrigo T.
Schuh, Andre C.
Yeh, Su-Peng
Daigle, Scott R.
Hui, Jianan
Zhang, Vickie
Pandya, Shuchi S.
Gianolio, Diego A.
de Botton, Stephane
Doehner, Hartmut
BLOOD, 2021, 138
[3] AGILE: A Global, Randomized, Double-Blind, Phase 3 Study of Ivosidenib plus Azacitidine Versus Placebo plus Azacitidine in Patients With Newly Diagnosed Acute Myeloid Leukemia With an IDH1 Mutation
Dohner, Hartmut
Montesinos, Pau
Polo, Susana Vives
Zarzycka, Ewa
Wang, Jianxiang
Bertani, Giambattista
Heuser, Michael
Calado, Rodrigo T.
Schuh, Andre C.
Yeh, Su-Peng
de la Fuente, Adolfo
Cerchione, Claudio
Daigle, Scott R.
Hui, Jianan
Pandya, Shuchi S.
Gianolio, Diego A.
Recher, Christian
de Botton, Stephane
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S234 - S234
[4] FDA Approval Summary: Ivosidenib in Combination with Azacitidine for Treatment of Patients with Newly Diagnosed Acute Myeloid Leukemia with an IDH1 Mutation
Woods, Ashley
Norsworthy, Kelly J.
Wang, Xin
Vallejo, Jonathon
Chow, Edwin Chiu Yuen
Li, Ruo-Jing
Sun, Jielin
Charlab, Rosane
Jiang, Xiling
Pazdur, Richard
Theoret, Marc R.
de Claro, R. Angelo
CLINICAL CANCER RESEARCH, 2024, 30 (07) : 1226 - 1231
[5] Phase 3, randomized, double-blind, placebo controlled study of venetoclax combined with azacitidine versus azacitidine in treatment-naive patients with acute myeloid leukemia.
Potluri, Jalaja
Xu, Tu
Hong, Wan-Jen
Mabry, Mack H.
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[6] ClarIDHy: A phase 3, multicenter, randomized, double-blind study of AG-120 vs placebo in patients with an advanced cholangiocarcinoma with an IDH1 mutation.
Lowery, Maeve Aine
Abou-Alfa, Ghassan K.
Valle, Juan W.
Kelley, Robin Kate
Goya, Lipika
Shroff, Rachna T.
Javle, Milind M.
Borad, Mitesh J.
Cleary, James M.
El-Khoueiry, Anthony B.
Bendell, Johanna C.
Macarulla, Teresa
Vogel, Arndt
Korth, Christopher
Jiang, Liewen
Gliser, Camelia
Wu, Bin
Agresta, Samuel V.
Pandya, Shuchi Sumant
Zhu, Andrew X.
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[7] ClarIDHy: A global, phase III, randomized, double-blind study of ivosidenib (IVO) vs placebo in patients with advanced cholangiocarcinoma (CC) with an isocitrate dehydrogenase 1 (IDH1) mutation
Abou-Alfa, G. K.
Macarulla Mercade, T.
Javle, M.
Kelley, R. K.
Lubner, S.
Adeva, J.
Cleary, J. M.
Catenacci, D. V.
Borad, M. J.
Bridgewater, J. A.
Harris, W. P.
Murphy, A. G.
Oh, D-Y.
Whisenant, J.
Wu, B.
Jiang, L.
Gliser, C.
Pandya, S. S.
Valle, J. W.
Zhu, A. X.
ANNALS OF ONCOLOGY, 2019, 30 : 872 - +
[8] Transform-1: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, International Phase 3 Study of Navitoclax in Combination with Ruxolitinib Versus Ruxolitinib Plus Placebo in Patients with Untreated Myelofibrosis
Pemmaraju, Naveen
Mead, Adam J.
Somervaille, Tim C. P.
McCloskey, James K.
Palandri, Francesca
Koschmieder, Steffen
Lavie, David
Leber, Brian
Yeh, Su-Peng
Gomez-Casares, Maria Teresa
Ammatuna, Emanuele
Shin, Ho-Jin
Kirito, Keita
Jourdan, Eric
Devos, Timothy
Chuah, Hun S.
Radinoff, Atanas
Bogdanovic, Andrija
Moskal, Rastislav
Jiang, Qi
Chopra, Avijeet S.
Papadopoulos, Elektra
Potluri, Jalaja
Passamonti, Francesco
BLOOD, 2023, 142
[9] A Randomized, Double-Blind, Placebo-Controlled Study of Venetoclax with Azacitidine Versus Azacitidine in Treatment-Naive Patients with Acute Myeloid Leukemia Ineligible for Intensive Therapy-Viale-A
DiNardo, Courtney D.
Jonas, Brian A.
Pullarkat, Vinod
Thirman, Michael J.
Garcia, Jacqueline S.
Wei, Andrew H.
Doehner, Hartmut
Fenaux, Pierre
Recher, Christian
Konopleva, Marina
Fiedler, Walter
Koller, Elisabeth
Havelange, Violaine
Schuh, Andre C.
Esteve, Jordi
Wang, Jianxiang
Vrhovac, Radovan
Hajek, Roman
Porkka, Kimmo
Illes, Arpad
Wolach, Ofir
Olivieri, Attilio
Yamamoto, Kazuhito
Jang, Jun-Ho
Juliusson, Gunnar
Vorobyev, Vladimir
Yeh, Su-Peng
Ozcan, Muhit
Hong, Wan-Jen
Zhou, Ying
Potluri, Jalaja
Pratz, Keith W.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S179 - S179
[10] Randomized, double-blind, placebo-controlled phase 3 study of ibrutinib plus rituximab in patients with previously untreated marginal zone lymphoma (MZL).
Noy, Ariela
Hughes, Stephanie
Biggar, Erin
Bogdan, Matthew
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)

← 1 2 3 4 5 →